Medtronic PLC

MDT03 Dec 2024
Healthcare
$86.17
0.00 (0.00%)
Lowest Today
$85.96
Highest Today
$86.85
Today’s Open
$86.17
Prev. Close
$86.54
52 Week High
$92.68
52 Week Low
$75.37
To Invest in Medtronic PLC

Medtronic PLC

Healthcare
MDT03 Dec 2024
0.00 (0.00%)
1M
3M
6M
1Y
5Y
Low
$85.96
Day’s Range
High
$86.85
85.96
52 Week Low
$75.37
52-Week Range
52 Week High
$92.68
75.37
1 Day
-
1 Week
+1.02%
1 month return
-4.34%
3 month return
-2.23%
6 month return
+7.4%
1 Year return
+9.26%
3 Years return
-18.85%
5 Years return
-21.94%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
9.63
BlackRock Inc
8.72
State Street Corp
4.69
Morgan Stanley - Brokerage Accounts
4.41
Vanguard Total Stock Mkt Idx Inv
3.16
Vanguard Institutional 500 Index Trust
2.65
Capital Research Global Investors
2.54

Market Status

Fundamentals
Market Cap
110623.15 mln
PB Ratio
2.28
PE Ratio
26.38
Enterprise Value
130959.79 mln
Total Assets
89981 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
Organisation
Medtronic PLC
Employees
95000
Industry
Medical Devices
CEO
Mr. Geoffrey Straub Martha
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step